Cargando…

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy

OBJECTIVE: We tested whether long-term treatment with the angiotensin II receptor antagonist irbesartan reduces nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria. RESEARCH DESIGN AND METHODS: The Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broedbaek, Kasper, Henriksen, Trine, Weimann, Allan, Petersen, Morten, Andersen, Jon T., Afzal, Shoaib, Jimenez-Solem, Espen, Persson, Frederik, Parving, Hans-Henrik, Rossing, Peter, Poulsen, Henrik E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114487/ https://www.ncbi.nlm.nih.gov/pubmed/21454798 http://dx.doi.org/10.2337/dc10-2214

Ejemplares similares

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study
por: Piazza, M., et al.
Publicado: (2020)

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
por: Persson, Frederik, et al.
Publicado: (2009)

Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial
por: Hellemons, Merel E., et al.
Publicado: (2011)

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review
por: Persson, Frederik, et al.
Publicado: (2016)

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
por: Reinhard, Henrik, et al.
Publicado: (2011)

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria
por: Andersen, Sten, et al.
Publicado: (2010)

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
por: Currie, Gemma E., et al.
Publicado: (2018)

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria
por: Poulsen, Christina Gjerlev, et al.
Publicado: (2023)

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
por: Gæde, Peter, et al.
Publicado: (2016)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
por: Zobel, Emilie H., et al.
Publicado: (2017)

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study
por: Oellgaard, Jens, et al.
Publicado: (2018)

Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus
por: Sana, Muhammad Ahsan, et al.
Publicado: (2020)

Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes
por: Broedbaek, Kasper, et al.
Publicado: (2014)

Biochemical effects of irbesartan in experimental diabetic nephropathy
por: Vaishya, Richa, et al.
Publicado: (2009)

Microalbuminuria in Type-2 Diabetes Mellitus; the tip of iceberg of diabetic complications
por: Ahmad, Tauseef, et al.
Publicado: (2017)

Effect of taurine and acetylcysteine in attenuating microalbuminuria in type 2 diabetes
por: Viswanathan, V., et al.
Publicado: (2008)

TNF-α and Microalbuminuria in Patients with Type 2 Diabetes Mellitus
por: Lampropoulou, I.-Th., et al.
Publicado: (2014)

Correlation between Microalbuminuria and Hypertension in Type 2 Diabetic Patients
por: Ali, Alia, et al.
Publicado: (2014)

Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia
por: Sun, Xiaomeng, et al.
Publicado: (2020)

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
por: Reinhard, Henrik, et al.
Publicado: (2011)

Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care 2007;30:1581–1583
Publicado: (2013)

Retinopathy and microalbuminuria in type II diabetic patients
por: Manaviat, Masoud R, et al.
Publicado: (2004)

Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
por: Xu, Qingmei, et al.
Publicado: (2021)

Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes
por: Haukka, Jani K., et al.
Publicado: (2018)

Serum osteoinductive factor is associated with microalbuminuria and diabetic nephropathy in type 2 diabetes
por: Wei, Wen, et al.
Publicado: (2018)

Association Between Urinary Markers of Nucleic Acid Oxidation and Mortality in Type 2 Diabetes: A population-based cohort study
por: Broedbaek, Kasper, et al.
Publicado: (2013)

Urinary Markers of Nucleic Acid Oxidation and Long-Term Mortality of Newly Diagnosed Type 2 Diabetic Patients
por: Broedbaek, Kasper, et al.
Publicado: (2011)

Prevalence of asymptomatic bacteriuria in type 2 diabetic subjects with and without microalbuminuria
por: Papazafiropoulou, Athanasia, et al.
Publicado: (2010)

Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients
por: Afkhami-Ardekani, M., et al.
Publicado: (2008)

Homocysteine as a Risk Factor for Development of Microalbuminuria in Type 2 Diabetes
por: Cho, Eun-Hee, et al.
Publicado: (2010)

Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes
por: HU, ZHI-JUAN, et al.
Publicado: (2014)

The association between EKG abnormalities and the development of microalbuminuria in type 2 diabetes
por: Chang, Yu-Kang, et al.
Publicado: (2021)

The Correlation between Microalbuminuria and Thyroid Nodules in Type 2 Diabetic Mellitus
por: Cao, Can, et al.
Publicado: (2022)

Incidence of Microalbuminuria and Factors Affecting It in Patients With Type 2 Diabetes Mellitus
por: Khan, Tayyab Mumtaz, et al.
Publicado: (2022)

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes
por: Ficociello, Linda H., et al.
Publicado: (2009)

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022)

Hypertension, poor glycemic control, and microalbuminuria in Cuban Americans with type 2 diabetes
por: Zarini, Gustavo G, et al.
Publicado: (2011)

Assessment of microalbuminuria and albumin creatinine ratio in patients with type 2 diabetes mellitus
por: Karar, Tarig, et al.
Publicado: (2015)

The Association Of Serum Cortisol Level With Microalbuminuria In Patients With Type 2 Diabetes And Prediabetes
por: Zhang, Xiaodan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_25fde3kp772ngo9mvcdg46ih75